Clinical Trial Update: Effects of a Kappa Agonist on Hot Flashes in Menopausal Women [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a kappa agonist for reducing menopausal hot flashes; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Kappa agonist

Snippet

Sponsor: University of Washington | Conditions: Treatment of Menopausal Hot Flashes | Phase 1 | Status: COMPLETED